Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring.

Danielsen I, Granström C, Rytter D, Halldorsson TI, Bech BH, Henriksen TB, Stehouwer CD, Schalkwijk CG, Vaag AA, Olsen SF.

Obesity (Silver Spring). 2014 May;22(5):1351-8. doi: 10.1002/oby.20650. Epub 2013 Dec 5.

PMID:
24167021
[PubMed - in process]
2.

Insulin resistance and impaired pancreatic β-cell function in adult offspring of women with diabetes in pregnancy.

Kelstrup L, Damm P, Mathiesen ER, Hansen T, Vaag AA, Pedersen O, Clausen TD.

J Clin Endocrinol Metab. 2013 Sep;98(9):3793-801. doi: 10.1210/jc.2013-1536. Epub 2013 Jun 24.

PMID:
23796568
[PubMed - indexed for MEDLINE]
3.

Dietary glycemic index during pregnancy is associated with biomarkers of the metabolic syndrome in offspring at age 20 years.

Danielsen I, Granström C, Haldorsson T, Rytter D, Hammer Bech B, Henriksen TB, Vaag AA, Olsen SF.

PLoS One. 2013 May 31;8(5):e64887. doi: 10.1371/journal.pone.0064887. Print 2013.

PMID:
23741411
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The influence of early exposure to vitamin D for development of diseases later in life.

Jacobsen R, Abrahamsen B, Bauerek M, Holst C, Jensen CB, Knop J, Raymond K, Rasmussen LB, Stougaard M, Sørensen TI, Vaag AA, Heitmann BL.

BMC Public Health. 2013 May 28;13:515. doi: 10.1186/1471-2458-13-515.

PMID:
23714352
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Does physical activity during pregnancy adversely influence markers of the metabolic syndrome in adult offspring? A prospective study over two decades.

Danielsen I, Granström C, Rytter D, Hammer Bech B, Brink Henriksen T, Vaag AA, Olsen SF.

J Epidemiol Community Health. 2013 Aug;67(8):648-54. doi: 10.1136/jech-2012-202017. Epub 2013 May 16.

PMID:
23682107
[PubMed - indexed for MEDLINE]
6.

The thrifty phenotype hypothesis revisited.

Vaag AA, Grunnet LG, Arora GP, Brøns C.

Diabetologia. 2012 Aug;55(8):2085-8. doi: 10.1007/s00125-012-2589-y. Epub 2012 May 30.

PMID:
22643933
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes.

Ferland-McCollough D, Fernandez-Twinn DS, Cannell IG, David H, Warner M, Vaag AA, Bork-Jensen J, Brøns C, Gant TW, Willis AE, Siddle K, Bushell M, Ozanne SE.

Cell Death Differ. 2012 Jun;19(6):1003-12. doi: 10.1038/cdd.2011.183. Epub 2012 Jan 6.

PMID:
22223106
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular disease.

Sonne MP, Højbjerre L, Alibegovic AC, Nielsen LB, Stallknecht B, Vaag AA, Dela F.

Exp Physiol. 2011 Oct;96(10):1000-9. doi: 10.1113/expphysiol.2011.058511. Epub 2011 Jul 1.

PMID:
21724735
[PubMed - indexed for MEDLINE]
Free Article
9.

Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.

Engelen L, Lund SS, Ferreira I, Tarnow L, Parving HH, Gram J, Winther K, Pedersen O, Teerlink T, Barto R, Stehouwer CD, Vaag AA, Schalkwijk CG.

Eur J Endocrinol. 2011 Mar;164(3):371-9. doi: 10.1530/EJE-10-0851. Epub 2011 Jan 4.

PMID:
21205874
[PubMed - indexed for MEDLINE]
Free Article
10.

Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus.

Lund SS, Petersen M, Frandsen M, Smidt UM, Parving HH, Vaag AA, Jensen T.

Clin Chem. 2011 Feb;57(2):298-308. doi: 10.1373/clinchem.2009.133868. Epub 2010 Oct 14. Erratum in: Clin Chem. 2011 May;57(5):782.

PMID:
20947697
[PubMed - indexed for MEDLINE]
Free Article
11.

Insulin regimens in type 2 diabetes.

Lund SS, Vaag AA.

N Engl J Med. 2010 Mar 11;362(10):959; author reply 960. doi: 10.1056/NEJMc0911551. No abstract available.

PMID:
20220196
[PubMed - indexed for MEDLINE]
Free Article
12.

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Lund SS, Tarnow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O, Parving HH, Vaag AA.

BMJ. 2009 Nov 9;339:b4324. doi: 10.1136/bmj.b4324.

PMID:
19900993
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

Diabetes Obes Metab. 2009 Oct;11(10):966-77. doi: 10.1111/j.1463-1326.2009.01079.x. Epub 2009 Jun 25.

PMID:
19558610
[PubMed - indexed for MEDLINE]
15.

Letter by Lund et al regarding article, "fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events".

Lund SS, Vaag AA, Jensen T.

Circulation. 2009 Apr 7;119(13):e384; author reply e385. doi: 10.1161/CIRCULATIONAHA.108.828111. No abstract available.

PMID:
19349329
[PubMed - indexed for MEDLINE]
Free Article
16.

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.

Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brøns C, Vilsbøll T, Hansen T, Madsbad S, Holst JJ, Vølund A, Poulsen P, Groop L, Pedersen O, Vaag AA.

Diabetologia. 2009 Jul;52(7):1298-307. doi: 10.1007/s00125-009-1307-x. Epub 2009 Mar 14.

PMID:
19288077
[PubMed - indexed for MEDLINE]
17.

Follow-up of intensive glucose control in type 2 diabetes.

Lund SS, Rossing P, Vaag AA.

N Engl J Med. 2009 Jan 22;360(4):416; author reply 418. doi: 10.1056/NEJMc082275. No abstract available.

PMID:
19164195
[PubMed - indexed for MEDLINE]
Free Article
18.

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.

Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, Parving HH, Vaag AA.

PLoS One. 2008;3(10):e3363. doi: 10.1371/journal.pone.0003363. Epub 2008 Oct 9.

PMID:
18852875
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Teerlink T, Gram J, Winther K, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 May;158(5):631-41. doi: 10.1530/EJE-07-0815.

PMID:
18426821
[PubMed - indexed for MEDLINE]
Free Article
20.

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46. doi: 10.1530/EJE-07-0500. Erratum in: Eur J Endocrinol. 2011 Nov;165(5):831.

PMID:
18166815
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk